Assessment of Anti-aging Efficacy of Marine Collagen Peptides

NCT ID: NCT06306105

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-04

Study Completion Date

2024-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To assess the anti-aging efficacy of Marine Collagen Peptides on skin, hair and finger nails for human

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Skin Condition Hair Fragility Nails, Ingrown

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

placebo drink

Group Type PLACEBO_COMPARATOR

placebo drink

Intervention Type DIETARY_SUPPLEMENT

consume 1 bottle per day

Marine Collagen Peptides drinks

Group Type EXPERIMENTAL

Marine Collagen Peptides

Intervention Type DIETARY_SUPPLEMENT

consume 1 bottle per day

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Marine Collagen Peptides

consume 1 bottle per day

Intervention Type DIETARY_SUPPLEMENT

placebo drink

consume 1 bottle per day

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Coral club Promarine Collagen Tripeptides

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy adults aged above 18 years old

Exclusion Criteria

* Subjects who are not volunteers
* Subjects who have been diagnosed with dermatitis, cirrhosis, and chronic kidney failure
* Subjects who have known cosmetic, drug or food allergies.
* Patients are taking medicine for chronic diseases
* Subjects receiving treatments for scalp, hair transplant, and other scalp medical care in past 12 weeks.
* Subjects getting a manicure and perm in past 12 weeks.
* Female who is pregnant or nursing or planning to become pregnant during the course of the study.
* Subjects receiving facial laser therapy, chemical peeling or UV overexposure (\> 3 hr/week) in the past 12 weeks.
* Students who are currently taking courses taught by the principal investigator of this trial.
* Subjects are not willing to reveal the results of pictures after taking the product
* Vegetarian.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

TCI Co., Ltd.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chia-Hua Liang, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Chia Nan University of Pharmacy & Science

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chia Nan University of Pharmacy & Science

Pingtung City, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

23-118-B

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.